Nutex Health (NUTX) Research & Development (2019 - 2022)
Nutex Health (NUTX) posted Research & Development of $73750.0 for Q1 2022, down 4.55% sequentially from $77265.0 in Q4 2021, and down 3.87% YoY from $76720.0 in Q1 2021.
Nutex Health (NUTX) Research & Development (2019 - 2022) Analysis & Trends
Nutex Health has reported Research & Development for 4 years, with the latest figure at $73750.0 in Q1 2022.
- Quarterly Research & Development fell 3.87% year-over-year to $73750.0 in Q1 2022, while the trailing twelve-month figure through Mar 2022 was $229985.0 (down 10.69% YoY) and the FY2021 annual result came in at $285880.0, down 48.7% from the prior year.
- Research & Development retreated to $73750.0 in Q1 2022 per NUTX's latest filing, from $77265.0 in the prior quarter.
- Over five years, Research & Development peaked at $282462.0 in Q2 2019 and troughed at $6704.0 in Q2 2021.
- A 4-year average of $97107.3 and a median of $73827.0 in 2020 frame the typical range for Research & Development.
- The sharpest annual moves came in 2020 and 2021: Research & Development surged 81.24% in 2020, then sank 87.27% in 2021.
- Over 4 years, Research & Development stood at $196632.0 in 2019, then tumbled by 72.39% to $54296.0 in 2020, then jumped by 42.3% to $77265.0 in 2021, then fell by 4.55% to $73750.0 in 2022.
- According to Business Quant data, Research & Development over the past three periods registered $73750.0, $77265.0, and $72266.0 for Q1 2022, Q4 2021, and Q3 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn | - |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn | - |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn | - |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn | - |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn | - |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn | - |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn | - |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn | - |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn | - |
| 10 | Nutex Health | 1.28 Bn | 1.19 Bn | 141.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 73,750.00 |
| Dec 31, 2021 | 77,265.00 |
| Sep 30, 2021 | 72,266.00 |
| Jun 30, 2021 | 6,704.00 |
| Mar 31, 2021 | 76,720.00 |
| Dec 31, 2020 | 54,296.00 |
| Sep 30, 2020 | 73,827.00 |
| Jun 30, 2020 | 52,669.00 |
| Mar 31, 2020 | 121,180.00 |
| Dec 31, 2019 | 196,632.00 |
| Sep 30, 2019 | 107,761.00 |
| Jun 30, 2019 | 282,462.00 |
| Mar 31, 2019 | 66,863.00 |